The US FDA has accepted an AI algorithm developed by Deliberate AI for a drug development tool pilot, focusing on anxiety and depression assessment. The use of AI in drug discovery and development is gaining traction in the pharmaceutical industry, with companies like RecursionPharma pioneering AI in pharma for over 10 years. However, there are discussions on the limitations of AI in revolutionizing pharmacology R&D. The potential of AI-driven engines, such as LOWE by RecursionPharma, to advance drug discovery is also being highlighted. The application of AI in drug discovery is being explored by various entities, with a focus on how it can streamline the process and potentially create medicines better than a human scientist.
More must-read coverage from @AndrewE_Dunn on the details of how AI is being applied in drug discovery. https://t.co/T0QRbFDTH4
Can AI create medicines better than a human scientist? https://t.co/ud6ZsOI6b9 via @BW
Have you seen @RecursionChris’ demo of #LOWE? Follow the link to see how our new AI-driven engine is advancing #drugdiscovery by simplifying complex workflows. ❓Got questions? Drop them below — we'll post our responses soon! 🔗 https://t.co/hMFF9vFfDy #TechBio #AI #ML $RxRx
Excited to share the latest post on our #DrugBaron blog - a helicopter view of the limitations of #AI in drug R&D: https://t.co/iOUNAYOeS0
New #DrugBaron post: Why claims that #AI will “revolutionise pharmacology R&D” are (almost entirely) hype… A deeper dive into the limits on what we can expect #AI to do in drug discovery and development https://t.co/IEmcSJYZNF
Synthetic Dreams: Data and AI Catalyze Drug Innovation. Read more: https://t.co/cjOBui7GxF https://t.co/K8YyGpJoOr
Pioneering #AI in pharma for over 10 years, and we're just getting started. 🚀 @Engadget's article highlights how AI is streamlining #drugdiscovery, echoing our journey in #TechBio. Read more: https://t.co/fjmYayxLZS $RxRx #ML #biotech
Congratulations to Ulupreneur @maafjes and the Deliberate AI team as the @US_FDA accepts their #AI algorithm to drug development tool pilot, with @deliberate_ai 's anxiety and depression assessment. Bravo! #AI #HealthTech https://t.co/CddFoSzGp8
For your AI radar ... #pinksheet #Pharma: An Artificial Intelligence Milestone For US FDA https://t.co/ZddYEt2t8j